Certified by Founder Lodge
UCL Technology Fund
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $4,700,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
The UCL Technology Fund is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base, focusing in particular on the physical
| Company | Date | Round | Raised |
|---|---|---|---|
Oriole Networks |
March, 28 ,2024 | Seed | $12,615,100 |
Carbon Re |
November, 07 ,2022 | Seed | $4,700,000 |
Intrinsic |
March, 14 ,2023 | Unknown | $8,510,000 |
Stanhope AI |
April, 08 ,2024 | Seed | $2,904,969 |
Phasecraft |
August, 16 ,2023 | Series A | $16,559,000 |
Gaussion |
August, 13 ,2024 | Series A | $12,000,000 |
Oriole Networks |
March, 28 ,2024 | Seed | $12,615,100 |
Stanhope AI |
April, 08 ,2024 | Seed | $2,904,969 |
Gaussion |
August, 13 ,2024 | Series A | $12,000,000 |
Oriole Networks
Carbon Re
Intrinsic
Stanhope AI
Phasecraft
Gaussion
Knit
CHARM Therapeutics
Curebase
SLAMcore Limited
Anthropic
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)